Royalty Pharma plc

RPD.MU·Munich·Healthcare
Compare
59.570.00 (0.00%)today
As of Nov 5, 8:14 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close59.57
Open59.57
Day range—
52-week range32.9459.57
Off day high0.00%
Off 52-week high0.00%
Volume0.00
Avg. volume (3M)0.00
Market cap34.42B
EPS (TTM)1.32
Forward P/E—
P/E ratio (TTM)45.13
Dividend yield1.41% (0.8400)
Beta (5Y)0.36
Shares outstanding445.28M
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin32.02%

Against its peers

Compare in full ›
RPD.MU ROIV REGN 3759.HK 0NZU.IL LGND
Market cap 34.42B 27.61B 96.28B 55.85B 14.40B 6.32B
P/E (TTM) 45.1 — 20.6 27.4 — 127.0
Forward P/E — -27.5 13.2 17.2 — 25.9
Price/book 4.4 6.5 2.8 2.8 8.1 6.6
Dividend yield 1.41% — 0.40% 0.78% — —
1-year change +71.18% +85.85% +43.87% +19.72% −43.38% +51.82%
Today 0.00% +6.08% −4.39% +3.47% +1.34% +0.83%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Royalty Pharma's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Roivant Sciences Ltd.ROIV · Biotechnology 27.61B 38.23 +6.08%
Regeneron Pharmaceuticals, Inc.REGN · Biotechnology 96.28B 930.67 −4.39%
Pharmaron Beijing Co., Ltd.3759.HK · Biotechnology 55.85B 30.400 +3.47%
Zealand Pharma A/S0NZU.IL · Biotechnology 14.40B 241.55 +1.34%
Ligand Pharmaceuticals IncorporatedLGND · Biotechnology 6.32B 316.13 +0.83%
Bio-Thera Solutions, Ltd.688177.SS · Biotechnology 7.38B 17.82 +2.95%
Shanghai Junshi Biosciences Co., Ltd.8SJ.F · Biotechnology 1.84B 1.7900 +1.70%
Fortrea Holdings Inc.FTRE · Biotechnology 2.01B 20.83 −0.57%

Also based in New York, New York, then elsewhere in New York.

Company Mkt cap Price Today
Citigroup Inc.C · New York, NYOdds 206.47B 124.74 +1.65%
Coinbase Global, Inc.COIN.BA · New York, NY 67.45T 9,435.00 +4.43%
The Bank of New York Mellon CorporationBNY.BA · New York, NY 43.07T 128,000.00 +2.58%
Verizon Communications Inc.VZ · New York, NYOdds 191.36B 46.17 +2.06%
Pfizer Inc.PFE · New York, NYOdds 175.50B 30.79 +2.63%
JPMorgan Chase & Co.JPM · New York, NYOdds 935.07B 352.11 +4.18%
Colgate-Palmolive CompanyCL.BA · New York, NY 14.28T 53,900.00 +1.60%
Morgan StanleyMS · New York, NYOdds 303.56B 193.97 +4.23%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All RPD.MU news ›
The Globe and Mail·Positive

Royalty Pharma (RPRX) Gets a Buy from Citi

In a report released today, Geoff Meacham from Citi maintained a Buy rating on Royalty Pharma, with a price target of $70.00. Meacham covers the Healthcare sector, focusing on stocks such as Amgen, Regeneron, and Biogen. According to…

RPRXREGNRXRX
The Motley Fool·

Should You Buy Royalty Pharma Stock Before Nov. 4?

Royalty Pharma (RPRX -0.70%) will report Q3 2026 earnings pre-market on Nov. 4. After pulling back in September due to a major setback with one of its drug candidates, the pharmaceutical royalty holding company's shares have been soaring…

LLYJNJMRKPFE
The Manila Times··3 outletsPositive

Royalty Pharma declares fourth quarter 2026 dividend

The Manila Times Royalty Pharma declares fourth quarter 2026 dividend NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of…

RPRXOR
More from 2 other outlets

From the 4Search news index, newest first.

In the news

30mentions in 30 days
30with it in the headline
Positivesentiment

Mentioned with

Novartis14Pfizer12Johnson & Johnson10Non-Gaap10Royalty Pharma Plc10Novo Nordisk9Eli Lilly8Merck & Co., Inc.8

People in the coverage

Thomas Niel21Prevymis18Danessa Lincoln14Abbvie12Sarita Garza10Tristan Rich10

Themes

Healthcare14Rprx13Pharmaceuticals11Comparison8Equities8Dividend7Dividends7Review7

Most coverage from

  1. marketscreener.com9
  2. marketbeat.com4
  3. themarketsdaily.com4
  4. fool.com3
  5. stocktitan.net3

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 30 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance